Companies /Healthcare

Quantum Cyber N.V.

NASDAQ: QUCY Diagnostics & Research
$0.55
▼ $0.03 (−5.48%) today
Markets closed · 11:56pm ET

QUCY at a Glance

Valuation
Market cap
$50.9M
Profitability
Revenue (TTM)
$1.5M
EPS (TTM)
$-2.38
Price
52-week range
$0 – $5
Street target
$9.00

Headquartered in Robert Koch Strasse 50, Mainz Fiscal year ends December NASDAQ: QUCY quantum-cyber.ai

About Quantum Cyber

Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. The company is headquartered in Mainz, Germany.

QUCY Coverage

Frequently Asked Questions

What does Quantum Cyber do?

Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. The company is headquartered in Mainz, Germany.

What is the QUCY stock price target?

The Wall Street consensus 12-month price target for QUCY is $9.00.